Typhoid Treatment Market: Global Industry Analysis and Forecast (2022-2029)

The Typhoid Treatment Market was valued at US$ 550.45 Mn. in 2021. Global Typhoid Treatment Market size is estimated to grow at a CAGR of 6.41% over the forecast period.
Typhoid Treatment Market Overview:
Typhoid is referred to as typhoid fever, infantile remittent fever, enteric fever, nervous fever, gastric fever, abdominal typhus, and sluggish fever, which is a bacterial infection caused by the bacterium Salmonella typhi. A typhoid infection causes a continuous high fever, headache, diarrhea, weakness, and loss of appetite, high body temperature up to 104 degrees Fahrenheit, among other symptoms. This infection has the potential to spread throughout the body, affecting a variety of organs. If typhoid fever is not treated promptly, it can progress to significant complications, including death. As a result, typhoid vaccination and treatment have become essential in preventing typhoid disease in people.To know about the Research Methodology:- Request Free Sample Report

Typhoid fever is a febrile sickness that can be fatal. Typhoid fever has a case fatality rate of 10–30% without treatment, although this drops to 1–4% with proper treatment. Young children are the most vulnerable to typhoid disease.
Typhoid Treatment Market Dynamics:
Growing regulatory mandates, along with an increase in the incidence of unhealthy lifestyles, are primarily driving the market growth. Rising expenditure on healthcare infrastructure development, growing morbidity and mortality rates due to typhoid infections, along with increased government initiatives to promote awareness, are fueling the typhoid treatment market growth across the globe. In addition, the availability of affordable typhoid drugs and cures are expected to provide profitable market growth prospects throughout forecast period.

According to the World Health Organization, there are an estimated 11–21 million cases of typhoid fever each year, with 128000–161000 deaths. Typhoid is an endemic disease across Africa, Latin America, Oceania, and the Caribbean. According to the WHO, 80% of typhoid fever cases occur in APAC nations such as India, China, Bangladesh, Nepal, and Indonesia. As a result, the growing prevalence of typhoid is driving the typhoid treatment market growth across the globe.

The Bill and Melinda Gates Foundation awarded the International Vaccine Institute (IVI) an US$15.7 million grant in April 2021 to conduct phase III clinical trials of Vi-DT, a typhoid conjugate vaccine (TCV) for long-term protection against typhoid infections. This funding is expected to help fund the development of an innovative new class of typhoid treatments.

The absence of early detection of infections is hampering the typhoid treatment market growth. Some constraints, such as the social shame associated with typhoid infections and their treatments, are expected to limit the market's growth during the forecast period.
In addition, in the Middle East Africa region, inadequate health care facilities are expected to stifle market growth.
Typhoid Treatment Market Segment Analysis:
Based on the Medication, the Typhoid Treatment Market is segmented into Antibiotics and Vaccines. The Antibiotics segment held the largest market share, accounting for 68.3% in 2021. The antibiotics typhoid treatment segment is further segmented into Chloramphenicol, Ciprofloxacin, Ceftriaxone, Ampicillin, and Trimethoprim-sulfamethoxazole. Antibiotics are one of the effective and efficient treatments for typhoid. Ciprofloxacin and ceftriaxone are the most widely prescribed antibiotics. If the bacteria are resistant to antibiotics, surgery is required. The approval and acceptance of more drugs are assisting the market's northward growth for this segment.

The Vaccine typhoid treatment segment is expected to witness significant market growth at a CAGR of 6.23% during the forecast period. Vaccines can help to avoid typhoid. Ty21a and ViCPS are the two vaccines now on the market for typhoid therapy. The government and Non-Profit organizations' initiatives to reduce the number of typhoid cases across the globe is driving the typhoid treatment market growth for this segment. For example, UNICEF procured an estimated US$ 2430 million typhoid doses of vaccines for roughly 100 countries in 2021, reaching approximately 45% of the world's children under the age of five.
Typhoid Treatment Market Regional Insights:
The North America region held the largest market share accounted for 41% in 2021. High typhoid prevalence, high-tech healthcare facilities, higher healthcare expenditure, reimbursement policies, increased awareness of typhoid and available treatments, and a well-structured regulatory framework is driving the typhoid treatment market growth in North America.

Asia Pacific region is expected to witness rapid growth at a CAGR of 5.93% during the forecast period. The region’s growth is attributed to rapidly enhancing medical infrastructure, growing disposable income, the availability of highly advanced healthcare facilities, rising healthcare spending, and government measures to reduce typhoid mortality rates. In addition, growing medical tourism industries in India, China, and Japan are expected to have much higher growth potential in the Asia Pacific typhoid treatment market throughout forecast period.

Despite having high typhoid mortality and morbidity rates, African countries are expected to have a low growth rate due to poorly developed health care facilities. As a result, the development of health care facilities in these countries is expected to slow the growth of the typhoid treatment market in these countries during the forecast period.

The objective of the report is to present a comprehensive analysis of the global Typhoid Treatment Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Typhoid Treatment Market dynamic, structure by analyzing the market segments and projecting the Typhoid Treatment Market size. Clear representation of competitive analysis of key players by Technology, price, financial position, product portfolio, growth strategies, and regional presence in the Typhoid Treatment Market make the report investor’s guide.
Typhoid Treatment Market Scope: Inquire before buying



Global Typhoid Treatment Market


Base Year
2021
Forecast Period
2022-2029


Historical Data
CAGR
Market Size in 2021
Market Size in 2029


2017 to 2021
6.41%
US$ 550.45 Mn
US$ 904.86 Mn


Segments Covered


by Medication
• Antibiotics
o Chloramphenicol
o Ciprofloxacin
o Ceftriaxone
o Ampicillin
o Trimethoprim-sulfamethoxazole
• Vaccines
o Inactivated(Killed) vaccine
o Live attenuated (weakened) vaccine
by Supportive Therapy
• Intravenous Fluids(IV)
• Intravenous Electrolyte Fluids
by End User
• Hospitals
• Homecare
• Specialty Clinics
• Others


Regions Covered


North America
• United States
• Canada
• Mexico
Europe
• UK
• France
• Germany
• Italy
• Spain
• Sweden
• Austria
• Rest of Europe
Asia Pacific
• China
• S Korea
• Japan
• India
• Australia
• Indonesia
• Malaysia
• Vietnam
• Taiwan
• Bangladesh
• Pakistan
• Rest of APAC
Middle East and Africa
• South Africa
• GCC
• Egypt
• Nigeria
• Rest of ME&A
South America
• Brazil
• Argentina
• Rest of South America



Typhoid Treatment Market Key Players are:
• GlaxoSmithKline
• Bharat Biotech
• Bayer
• Sanofi S.A
• Pfizer
• Mallinckrodt
• Lupin
• Salix Pharmaceuticals
• Bill & Melinda Gates Foundation
• Bharat Biotech
• GlaxoSmithKline plc.
• BIO-MED
• Bio Farma
• Amgen Inc.
• Johnson & Johnson Services, Inc.
• Promega Corporation
• Takeda Pharmaceutical Company Limited
• Merck KGaA
• Blueberry Therapeutics Ltd
• Mylan N.V.
• FDC
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Akorn Operating Company LLC
Frequently Asked Questions:
1] What segments are covered in the Typhoid Treatment Market report?
Ans. The segments covered in the Typhoid Treatment Market report are based on Medication, Supportive Therapy, and End User.

2] Which region is expected to hold the highest share in the Typhoid Treatment Market?
Ans. The North America region is expected to hold the highest share in the Typhoid Treatment Market.

3] What is the market size volume of the Typhoid Treatment Market by 2029?
Ans. The market size of the Typhoid Treatment Market by 2029 is expected to reach US$ 904.86 Mn.

4] What is the forecast period for the Typhoid Treatment Market?
Ans. The forecast period for the Typhoid Treatment Market is 2021-2029.

5] What was the market size volume of the Typhoid Treatment Market in 2021?
Ans. The market size of the Typhoid Treatment Market in 2021 was valued at US$ 550.45 Mn.